Comparison of Fentanyl Oral and Nasal Formulations #331

ACTIQ (fentanyl citrate) Oral Transmucosal Lozenge. Frazier, PA: Cephalon, Incorporated, 2016. Package insert.

Fentanyl Citrate (Fentanyl Citrate) Lozenge. St. Louis, MO: Mallinckrodt, Inc., 2012. Package insert.

ABSTRAL (Fentanyl Citrate) Tablet. Lake Oswego, OR: Galena BioPharma, Inc., 2014. Package insert.

FENTORA (Fentanyl Citrate) Tablet. North Wales, PA: Cephalon, Inc., 2013. Package insert.

ONSOLIS (Fentanyl Citrate) Film, Soluble. Solna, Sweden: Meda Pharmaceuticals, Inc., 2011. Package insert.

SUBSYS (Fentanyl Citrate) Spray. Chandler, AZ: Insys Therapeutics, Inc., 2014. Package insert.

LAZANDA (Fentanyl Citrate) Spray. Newark, CA: Depomed, Inc., 2015. Package insert

Schechter NL , Weisman SJ , Rosenblum M , et al.: The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics, 1995; 95:335–339.

Taylor DR , Webster LR , Chun SY , et al.: Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC^®, ACTIQ^®). Pain Med, 2007; 8:281–288.

Portenoy RK , Messina J , Xie F , Peppin J : Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: A randomized, placebo-controlled study. Curr Med Res Opin, 2007; 23:223–233.

Jandhyala R , Fullarton JR , Bennett MI : Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. J Pain Symptom Manage, 2013; 46:573–580.

Mercadante S , Villari P , Ferrera P , et al.: Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer, 2007; 96:1828–1833.

Finn J , Wright J , Fong J , et al.: A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns. Burns, 2004; 30:262–268.

Rickard C , O'Meara P , McGrail M , et al.: A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting. Am J Emerg Med, 2007; 25:911–917.

Portenoy RK , Burton AW , Gabrail N , Taylor D : A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain. Pain, 2010; 151:617–624.

Mercadante S , Adile C , Cuomo A , et al.: Fentanyl buccal tablet vs oral morphine in doses proportional to basal opioid regimen for the management of breakthrough cancer pain: A randomized, crossover, comparison study. J Pain Symptom Manage, 2015; 50:579–586.

Mercadante S , Aielli F , Adile C , et al.: Fentanyl pectin nasal spray versus oral morphine in doses proportional to basal opioid regimen for the management of breakthrough cancer pain: A comparitive study. J Pain Symptom Manage, 2016; 52:27–34.

Zecca E , Brunelli C , Centurioni F , et al.: Fentanyl sublingual tablets versus subcutaneous morphine for the management of severe cancer pain episodes in patients receiving opioid treatment: a double-blind, randomized, noninferiority trial. J Clin Oncol, 2017; 35:759–765.